Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2026-04-07 Report Publication Anno…
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta Group SA publishes 2026 Annual General Meeting invitation
Report Publication Announcement Classification · 1% confidence The document is a press release announcing that Medacta Group SA has published the invitation (proxy materials) for its 2026 Annual General Meeting and provides a link to the full invitation. It does not itself present full AGM materials or acts as the actual proxy statement; rather, it simply notifies stakeholders that the invitation has been released. Under the "Menu vs Meal" rule, short announcements stating that a report or invitation has been published and linking to it are classified as Report Publication Announcements (RPA).
2026-04-07 English
Medacta Group SA publishes 2026 Annual General Meeting invitation
AGM Information Classification · 1% confidence The document is a press release providing the invitation, date, time, location, agenda motions, and registration details for Medacta Group SA’s 2026 Annual General Meeting. It is not the full annual report, earnings release, or proxy statement but rather AGM materials (invitation and agenda), which fits the AGM Information category.
2026-04-07 English
Medacta selected as partner for groundbreaking international research project
Regulatory Filings Classification · 1% confidence The document is a corporate media release (press announcement) providing miscellaneous project news (an April Fools research collaboration note) rather than financial results, board changes, dividends, or any formal report. It does not fit any specific category such as Annual Report, Earnings Release, M&A, etc. It is a general exchange news announcement, so it falls under the fallback category Regulatory Filings (RNS).
2026-04-01 English
Medacta selected as partner for groundbreaking international research project
Regulatory Filings Classification · 1% confidence The document is a company media release announcing Medacta’s selection as a partner for an international research project. It contains no financial results, regulatory vote outcomes, capital structure changes, legal proceedings, or meeting materials. It is a general corporate announcement via EQS News and fits none of the specific filing categories (e.g., earnings release, annual report, M&A, etc.). Therefore, it should be classified under the fallback category: Regulatory Filings (RNS).
2026-04-01 English
Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
Earnings Release Classification · 1% confidence The document is an 'ad-hoc announcement' detailing the company's full-year 2025 financial results, including revenue, EBITDA, net profit, and future guidance. It provides key highlights and performance metrics but explicitly directs the reader to the '2025 Annual Report' for further financial details. Because it is an initial announcement of results rather than the full annual report itself, and it contains the core financial highlights, it is classified as an Earnings Release. FY 2025
2026-03-13 English
Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
Earnings Release Classification · 1% confidence The document is an 'ad hoc announcement' regarding the company's full-year 2025 financial results. It provides key highlights, financial metrics, and outlook statements, but explicitly directs the reader to the '2025 Annual Report' for further financial details. Because it is a summary announcement of results rather than the full annual report itself, and it does not meet the criteria for a full 10-K or IR, it is classified as an Earnings Release (ER). FY 2025
2026-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.